Walgreens teams up with Verily to tackle chronic conditions

Walgreens Boots Alliance has teamed up with Verily, the life sciences unit of Google parent company Alphabet. The two companies will focus on improving outcomes for patients with chronic conditions, CNBC reported.

The partnership will deploy Verily’s technology at Walgreens’ pharmacies and specifically focus on medication adherence, an issue that costs the healthcare system about $100 billion to $289 billion annually.

The partnership may help Walgreens connect more technology to its growing healthcare services and could signal a move to fend off competitors like CVS Health, which recently acquired health insurance provider Aetna, and Amazon, which has continued to step into the pharmacy and healthcare space.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup